IMNM
Price
$9.84
Change
-$0.62 (-5.93%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
859.13M
6 days until earnings call
ITOS
Price
$10.13
Change
+$0.01 (+0.10%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
446.57M
Earnings call today
Interact to see
Advertisement

IMNM vs ITOS

Header iconIMNM vs ITOS Comparison
Open Charts IMNM vs ITOSBanner chart's image
Immunome
Price$9.84
Change-$0.62 (-5.93%)
Volume$60.87K
Capitalization859.13M
iTeos Therapeutics
Price$10.13
Change+$0.01 (+0.10%)
Volume$17.7K
Capitalization446.57M
IMNM vs ITOS Comparison Chart in %
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. ITOS commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Hold and ITOS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (IMNM: $10.46 vs. ITOS: $10.11)
Brand notoriety: IMNM and ITOS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 57% vs. ITOS: 91%
Market capitalization -- IMNM: $859.13M vs. ITOS: $446.57M
IMNM [@Biotechnology] is valued at $859.13M. ITOS’s [@Biotechnology] market capitalization is $446.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileITOS’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • ITOS’s FA Score: 1 green, 4 red.
According to our system of comparison, both IMNM and ITOS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 3 TA indicator(s) are bullish while ITOS’s TA Score has 3 bullish TA indicator(s).

  • IMNM’s TA Score: 3 bullish, 5 bearish.
  • ITOS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ITOS is a better buy in the short-term than IMNM.

Price Growth

IMNM (@Biotechnology) experienced а -2.70% price change this week, while ITOS (@Biotechnology) price change was -0.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.15%. For the same industry, the average monthly price growth was +8.44%, and the average quarterly price growth was +12.41%.

Reported Earning Dates

IMNM is expected to report earnings on Aug 13, 2025.

ITOS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+1.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($859M) has a higher market cap than ITOS($447M). ITOS YTD gains are higher at: 31.641 vs. IMNM (-1.507). ITOS has higher annual earnings (EBITDA): -146.71M vs. IMNM (-175.18M). ITOS has more cash in the bank: 520M vs. IMNM (317M). IMNM has less debt than ITOS: IMNM (4.77M) vs ITOS (5.05M). ITOS has higher revenues than IMNM: ITOS (35M) vs IMNM (10.9M).
IMNMITOSIMNM / ITOS
Capitalization859M447M192%
EBITDA-175.18M-146.71M119%
Gain YTD-1.50731.641-5%
P/E RatioN/AN/A-
Revenue10.9M35M31%
Total Cash317M520M61%
Total Debt4.77M5.05M94%
TECHNICAL ANALYSIS
Technical Analysis
IMNMITOS
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 3 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 17 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
69%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PUMYX15.04N/A
N/A
PACE Small/Medium Co Growth Equity Y
PMYRX12.78N/A
N/A
Victory Pioneer Equ Premium Income Y
SVFKX78.56N/A
N/A
Smead Value R2
GCSCX19.53N/A
N/A
Goldman Sachs Small Cap Eq Insghts C
CLRYX21.80N/A
N/A
Columbia Large Cap Growth Opp Inst3

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-3.59%
IDYA - IMNM
61%
Loosely correlated
-2.03%
RXRX - IMNM
55%
Loosely correlated
-0.90%
ARWR - IMNM
54%
Loosely correlated
-0.97%
SYRE - IMNM
54%
Loosely correlated
-5.39%
DNTH - IMNM
53%
Loosely correlated
-4.00%
More

ITOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITOS has been loosely correlated with BMRN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ITOS jumps, then BMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITOS
1D Price
Change %
ITOS100%
N/A
BMRN - ITOS
49%
Loosely correlated
-2.03%
IBO - ITOS
45%
Loosely correlated
-3.70%
BDTX - ITOS
43%
Loosely correlated
-1.47%
IMNM - ITOS
41%
Loosely correlated
-3.59%
OCUL - ITOS
40%
Loosely correlated
+4.17%
More